Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Prizes

iCMLf

Education

Virtual Education Program

    Susan Branford - the importance of Molecular Monitoring in CML

    The importance of Molecular Monitoring in CML

    Susan Branford, University of Adelaide, Australia

    Please click on the image below to watch the webcast, and a window will open. You can then also click on the slides to jump to certain sections of the presentation. Please share your feedback below, and view the other Virtual Education Program modules.

     

    webcast-button
    vep branford molecmonitoring

    		 

    Issues covered

    • Measurement of BCR-ABL transcript levels to assess residual disease
    • Recommended monitoring for CML
    • The significance of achieving a major molecular response

    Has this been helpful? Please provide your comments here:

    Facteur de variabilité de la réponse au ITK</li>
                  <li>Les trois grand mécanismes de résistance</li>
                  <li>La réponse au traitement</li>
                  <li>Autres inhibiteurs de tyrosine kinase: le Nilotinib et le Dasatinib